Related Articles
Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke
Temporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patients
Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study
DL‑3‑n‑butylphthalide therapy for Parkinson's disease: A randomized controlled trial
Dl‑butylphthalide inhibits rotenone‑induced oxidative stress in microglia via regulation of the Keap1/Nrf2/HO‑1 signaling pathway